New drug from Gensight Biologics hits pipeline
Bernard Gilly, PhD
Advertisement
CEO, Gensight Biologics
Articles by Bernard Gilly, PhD
Advertisement
Latest Updated Articles
Pipeline: New therapies to come for debilitating eye diseasesNovember 12th 2020
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Simplifying the treatment of ocular surface disease
2
Classifying dry eye by root cause: A step toward precision medicine
3
3D-printed contact lenses offer patient-specific fit in 20 minutes
4
Atropine, aspherical lenses enter trial for childhood myopia
5